U.S. Markets open in 39 hrs, 48 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 8.49 09:44 AM EDT | |
|---|---|---|
| Day High | 8.80 11:51 AM EDT |
|
| Range | 0.31 |
| Volume | 401,981 | |
|---|---|---|
| 30-Day Avg Vol | 542,000 |
|
| Difference | -25.83% |
| Market Cap | 445.16 M | |
|---|---|---|
| Mkt Cap Chg | -1.02 M |
| Shares Out | 51.10 M | |
|---|---|---|
| % Shrs Traded | 0.79% | |
| 1yr EPS Est | -0.593 |
| 52-Wk Low | 2.47 10/10/08 | |
|---|---|---|
| 52-Wk High | 8.85 7/1/09 |
|
| Range | 6.38 |
| Prev Close | 8.73 7/1/09 | |
|---|---|---|
| Today's Open | 8.60 | |
| Change | -1.49% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 1.78 M |
| Revenue (LFY) | 40.24 M | |
|---|---|---|
| Earnings (LFY) | -32.02 M | |
| Earnings (MRQ) | -4.61 M | |
| Next Earn Est | -0.175 | |
| Next Earnings | 04/29/2010 |
|
| EPS (TTM) | -0.69 | |
| 1yr EPS Growth | 14.06% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -14.00 | |
| PEG Ratio | — | |
| Return on Equity | -87.90 | |
| Beta | 1.91 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
ImmunoGen is TAPping into cancer research. The firm's product candidates are TAPs, or tumor-activated prodrugs, that combine cancer-killing drugs with monoclonal antibodies and attach only to tumor cells. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.175 8/6/09 | — — |
—
—
|
| Last Quarter | -0.095 3/31/09 | -0.09 3/31/09 |
0.005
Beat
|
| 2 Quarters Ago | -0.148 12/31/08 | -0.14 12/31/08 |
0.008
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 8.23 M | 40.25 M |
| Gross Profit | 8.23 M | 35.80 M |
| Operating Income | -4.51 M | -34.11 M |
| Net Income | -4.61 M | -32.02 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts